Key TakeawaysHigh-risk adults as young as 50 are now eligible for the RSV vaccineThe update follows advice from now-deposed ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Inside one of those nondescript rooms last week, the Advisory Committee on Immunization Practices (ACIP), an independent ...